Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -1.17 | 40.21 |
| PEG Ratio (TTM) | 0.39 | 0.19 |
| P/S Ratio (TTM) | -1.57 | 3.35 |
| P/B Ratio (TTM) | 0.56 | 0.74 |
| P/FCF Ratio (TTM) | -13.59 | -57.26 |
| Price to 5YR AVG Earnings Ratio | -42.23 | 70.57 |
| Price to 5YR AVG FCF Ratio | 4.27 | 5.86 |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -13.68% | 0.79% |
| ROE (TTM) | -44.18% | 6.20% |
| Net Profit Margin (TTM) | 134.47% | 26.96% |
| ROIC 5YR AVG | 2.09% | 5.03% |
Growth (43%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -285.17% | 332.01% | 72.03% |
| Revenue | -153.65% | -5.64% | -24.54% |
| Net Income | -103.89% | 354.42% | 145.57% |
| Cash Flow | 12.85% | 0.69% | -858.09% |
Health (28%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | 5.83 |
| Quick Ratio (TTM) | N/A | 5.77 |
| D/E Ratio (TTM) | 1.52 | 2.59 |
| Interest Coverage (TTM) | -0.03 | 0.18 |
| Piotroski F-Score | 5 | 4 |
| Altman Z-Score | N/A | 0.42 |
| LTL to 5YR AVG FCF | 19.37 | 8.39 |
| Shares Outstanding Growth 5YR AVG | -12.90% | 10.76% |